Bacterial extract (OM-85) with human-equivalent doses does not inhibit the development of asthma in a murine model

Allergologia et Immunopathologia

Volumn 44, Issue 6, 2016, Pages 504-511

  Rodrigues, A ^a   Gualdi, L P ^a   de Souza, R G ^a   Vargas, M H M ^a   Nunez N K ^a   da Cunha, A A ^a   Jones, M H ^a   Pinto, L A ^a   Stein, R T ^a   Pitrez, P M ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Asthma; Inflammation; Mice; OM 85

Indexed keywords

BACTERIUM LYSATE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OM 85; OVALBUMIN; UNCLASSIFIED DRUG; BRONCHO-VAXOM; CELL EXTRACT; CYTOKINE;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DOSE RESPONSE; DRUG EFFICACY; DRUG SENSITIZATION; EOSINOPHIL COUNT; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FUNCTION; MOUSE; NONHUMAN; PRIMARY PREVENTION; SERUM; SINGLE DRUG DOSE; TREATMENT RESPONSE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; DRUG EFFECTS; EOSINOPHIL; HUMAN; IMMUNIZATION; IMMUNOLOGY; METABOLISM;

ANIMALS; ASTHMA; CELL EXTRACTS; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN E; MICE; MICE, INBRED BALB C;

EID: 85017492987     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2016.04.010     Document Type: Article

References (27)

1. 1 Global strategy for asthma management and prevention [database on the Internet]. 2009 Available from: http://www.ginasthma.org [cited March 2014].
2. 2 Forsythe, P., Probiotics and lung immune responses. Ann Am Thorac Soc 11:Suppl. 1 (2014), S33–S37.
3. 3 Azad, M.B., Coneys, J.G., Kozyrskyj, A.L., Field, C.J., Ramsey, C.D., Becker, A.B., et al. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ, 347, 2013, f6471.
4. 4 Elazab, N., Mendy, A., Gasana, J., Vieira, E.R., Quizon, A., Forno, E., Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics 132 (2013), e666–e676.
5. 5 Sly, P.D., Kusel, M., Holt, P.G., Do early-life viral infections cause asthma?. J Allergy Clin Immunol 125 (2010), 1202–1205.
6. 6 Jackson, D.J., Early-life viral infections and the development of asthma: a target for asthma prevention. Curr Opin Allergy Clin Immunol 14 (2014), 131–136.
7. 7 Braun-Fahrlander, C., Riedler, J., Herz, U., Eder, W., Waser, M., Grize, L., et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347 (2002), 869–877.
8. 8 Huber, M., Mossmann, H., Bessler, W.G., Th1-orientated immunological properties of the bacterial extract OM-85-BV. Eur J Med Res 10 (2005), 209–217.
9. 9 Razi, C.H., Harmanci, K., Abaci, A., Özdemir, O., Hızlı, S., Renda, R., et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 126 (2010), 763–769.
10. 10 Strickland, D.H., Judd, S., Thomas, J.A., Larcombe, A.N., Sly, P.D., Holt, P.G., Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control. Mucosal Immunol 4 (2011), 43–52.
11. 11 Del-Rio-Navarro, B.E., Espinosa Rosales, F., Flenady, V., Sienra-Monge, J.J., Immunostimulants for preventing respiratory tract infection in children. Cochrane Database Syst Rev, 2006, CD004974.
12. 12 Weinberger, M., Can we prevent exacerbations of asthma caused by common cold viruses. J Allergy Clin Immunol 126 (2010), 770–771.
13. 13 Mestecky, J., The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 7 (1987), 265–276.
14. 14 Navarro, S., Cossalter, G., Chiavaroli, C., Kanda, A., Fleury, S., Lazzari, A., et al. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol 4 (2011), 53–65.
15. 15 Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited. FASEB J 22 (2008), 659–661.
16. 16 Hantos, Z., Petak, F., Adamicza, A., Asztalos, T., Tolnai, J., Fredberg, J.J., Mechanical impedance of the lung periphery. J Appl Physiol 83 (1997), 1595–1601.
17. 17 Broug-Holub, E., Kraal, G., In vivo study on the immunomodulating effects of OM-85 BV on survival, inflammatory cell recruitment and bacterial clearance in Klebsiella pneumonia. Int J Immunopharmacol 19 (1997), 559–564.
18. 18 Mauel, J., Macrophage activation by OM-85 BV. Respiration 59:Suppl. 3 (1992), 14–18.
19. 19 Mauel, J., Stimulation of immunoprotective mechanisms by OM-85 BV. A review of results from in vivo and in vitro studies. Respiration 61:Suppl. 1 (1994), 8–15.
20. 20 Paupe, J., Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. Respiration 58 (1991), 150–154.
21. 21 Wybran, J., Libin, M., Schandene, L., Activation of natural killer cells and cytokine production in humans by bacterial extracts (OM-85 BV). Lung 168:Suppl. (1990), 720–725.
22. 22 Bitar, M.A., Saade, R., The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children. Int J Pediatr Otorhinolaryngol 77 (2013), 670–673.
23. 23 Derenne, J.P., Delclaux, B., Clinical experience with OM-85 BV in upper and lower respiratory tract infections. Respiration 59:Suppl. 3 (1992), 28–31.
24. 24 Schaad, U.B., OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr 6 (2010), 5–12.
25. 25 Schaad, U.B., Mutterlein, R., Goffin, H., Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 122 (2002), 2042–2049.
26. 26 Han, L., Zheng, C.P., Sun, Y.Q., Xu, G., Wen, W., Fu, Q.L., A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice. Am J Rhinol Allergy 28 (2014), 110–116.
27. 27 Robinson, D.S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A.M., et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326 (1992), 298–304.